A clinical perspective argued that sedation practice, screening, family contact, and environmental design all matter to delirium prevention. It did not test a single architecture or drug intervention.
The authors discussed pandemic-related disruptions in delirium monitoring and care, including more benzodiazepine use and restricted visitation. They advocated integrating pain control, appropriate wakefulness, mobility, family engagement, and environmental improvements.
Proposals addressed lighting, noise, room arrangement, communication, and individualized comfort alongside pharmacologic care.
The article synthesized concerns and proposed a future care model rather than randomly assigning ICU design or medication. It cannot quantify how much delirium any one change would prevent.
Nor does it establish that every delirium episode in a sedated patient was caused by benzodiazepines. Forensic interpretation should examine the full clinical environment and serial assessments. A systems-level recommendation can identify questions for review while leaving individual drug attribution, preventability, and the effects of a particular room design unresolved.
Original analysis of the supplied journal article, identified as PMC9254432.